Lithium and psoriasis: Cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium

Archives of Dermatological Research

Volumn 288, Issue 4, 1996, Pages 173-178

  Ockenfels, Hans M ^a,b   Wagner, Stephan N ^a   Keim Maas, Christina ^a   Funk, Renate ^a   Nussbaum, Gregor ^a   Goos, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cocultures; Cytokines; Lithium; Psoriasis

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LITHIUM; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL INFILTRATION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTE; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SUPERNATANT; T LYMPHOCYTE;

EID: 0029978775     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02505220     Document Type: Article

References (38)

1. Abel EA, DiCocco LM, Orenberg EK, Fraki JE, Farber EM (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15:1007-1022
2. Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94:101S-107S
3. Antilla HSI, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M (1992) Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 98:96-101
4. Baker S, Frey L (1992) The immunology of psoriasis. Br J Dermatol 126:1-9
5. Barker JNWN (1991) The pathophysiology of psoriasis. Lancet 338:227-230
6. Barker JNWN, Groves RW, Allen MH, MacDonald DM (1992) Preferential adherence of T lymphocytes and neutrophils to psoriatic epidermis. Br J Dermatol 127:205-211
7. Beyaert R, Schulze-Osthoff K, Roy F van, Fiers W (1992) Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 22: 2181-2184
8. Boyce S, Ham RG (1983) Normal human epidermal keratinocytes. In: Weber MM, Sekely L (eds) In vitro models for cancer resarch. CRC Press, Boca Raton, pp 245-274
9. Castells-Rodellas A, Castell JV, Ramirez-Bosca A, Nicolas JF, Valcuende-Cavero F, Thivolet J (1992) Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (Stockh) 72:165-168
10. Chang EY, Hammerberg C, Fisher G, Baadsgaard O (1992) T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch Dermatol 128:1479-1485
11. Delaporte E, Bieber T, Viac J, Faure M, Nicolas J-F (1994) Cytokine éidermiques et inflammation cutanée. Ann Dermatol Venereol 121:836-843
12. Elder JT, Klein SB, Tavakkol A, Fisher GJ, Nickoloff BJ, Voorhees JJ (1990) Growth factor and proto-oncogene expression in psoriasis. J Invest Dermatol 95:7S-9S
13. Fierlbeck G, Rasser G, Müller C (1990) Psoriasis induced at the injection site of recombinant interferon gamma. Arch Dermatol 126:351-355
14. Fivenson DP, Nickoloff BJ, Sae GM (1994) Quantitative PCR analysis of Th1 cytokines in HUT 78 cells after exposure to PUVA in vitro. J Invest Dermatol 102:587
15. Furue M, Gaspari AA, Katz SI (1988) The effect of CyA on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 90:796-800
16. Gearing AJH, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE, Camp RDR (1990) Cytokines in skin lesions of psoriasis. Cytokine 2:68-75
17. Gilitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G (1991) Upper keratinocytes of psoriatic skin lesions express high levels of NAP-I/II-8 mRNA in situ. J Invest Dermatol 97: 73-79
18. Gomi T, Shiora T, Munakata T (1991) Interleukin-1α, tumor-necrosis factor-α, and interferon-γ in psoriasis. Arch Dermatol 127:827-830
19. Gottlieb AB (1990) Immunologic mechanisms in psoriasis. J Invest Dermatol 95:18S-19S
20. Kemény L, Michel G, Bobozy A, Ruzicka T (1994) Cytokine system as potential target for antipsoriatic therapy. Exp Dermatol 3:1-8
21. Kishimoto T (1992) Interleukin-6 and its receptor; from cloning to clinic. Int Arch Allergy Immunol 99:172-177
22. Krueger JG, Krane JF, Carter DM, Gottlieb AB (1990) Role of growth factors, cytokines and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S-140S
23. Lambert D, Beer F, Gisselman R, Bouilly D, Chapuis J-L (1982) Manifestation cutanées des thérapeutiques par le lithium. Ann Dermatol Venereol 109:19-24
24. Lazarus GS, Gilgor RS (1979) Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. Arch Dermatol 115: 1183-1184
25. Luger TA, Schwarz T (1990) Evidence for an epidermal cytokine network. J Invest Dermatol 95:100S-104S
26. 125I]Epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 86:260-265
27. Neuner P, Urbanski A, Trautinger F, Möller A, Kirnbauer R, Kapp A, Schöpf E, Schwarz T, Luger TA (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97:27-33
28. Nickoloff BJ, Baham TY, Merigan TC, Morhenn VB (1984) Anti-proliferative effects of recombinant α and γ-interferons on cultured human keratinocytes. Lab Invest 51:697-701
29. Nickoloff BJ, Mitra RS, Shimizu Y, Barker JNWN, Karabin G, Stoof T, Stoolman LM (1992) HUT 78 T cells bind to noncytokine-stimulated keratinocytes using a non-CD18-dependent adhesion pathway. Am J Pathol 140:1365-1374
30. Powrie F, Coffman RL (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 14:270-274
31. Prinz JC, Groß B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G (1994) T cell clones form psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 24:593-598
32. Sauder DN (1990) The role of epidermal cytokines in inflammatory skin diseases. J Invest Dermatol 95:27S-28S
33. Savelkoul HFJ, Debets R (1993) Cytokine antagonists and their potential therapeutic use. Immunol Today 15:455-458
34. Sharma SD (1982) Lithium modulates mitogen induced natural killer activity and interferon production. J Immunopharmacol 4: 303-312
35. Sticherling M, Bornscheuer E, Schröder J-M, Christophers E (1991) Localization of Nap-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 96:26-30
36. Stoof TJ, Mitra RS, Sarma V, Dixit VM, Nickoloff BJ (1992) Keratinocyte activation following T lymphocyte binding. J Invest Dermatol 98:92-95
37. Strange P, Cooper KD, Hansen ER, Fisher G, Larsen JK, Fox D, Krag C, Voorhees JJ, Baadsgaard O (1993) T-lymphocyte clones from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 101: 695-700
38. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterised by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705